HDAC9 and pulmonary fibrosis: Since histone acetylation and deacetylation might play an important role in the pathogenesis of inflammatory lung diseases [9,20], HDAC inhibitors were already suggested to provide protection against lung fibrosis to altered gene expression after hyperacetylation [7,21].